# A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

> **NCT01915147** · PHASE2 · COMPLETED · sponsor: **Mundipharma Research GmbH & Co KG** · enrollment: 108 (actual)

## Conditions studied

- Severe Chronic Pain

## Interventions

- **DRUG:** OXN PR followed by OxyPR tablets
- **DRUG:** OxyPR followed by OXN PR tablets

## Key facts

- **NCT ID:** NCT01915147
- **Lead sponsor:** Mundipharma Research GmbH & Co KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-02
- **Final completion:** 2015-09
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915147, "A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01915147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*